IgA nephropathy.
McCoy RC, Abramowsky CR, Tisher CC.
Am J Pathol. 1974 Jul;76(1):123-44.
Immunologic studies in IgA nephropathy.
Woodroffe AJ, Gormly AA, McKenzie PE, Wootton AM, Thompson AJ, Seymour AE, Clarkson AR.
Kidney Int. 1980 Sep;18(3):366-74. doi: 10.1038/ki.1980.147.
The effect of age on the character of immune complex disease: a comparison of the incidence and relative size of materials reactive with Clq in sera of patients with glomerulonephritis and cancer.
Rossen RD, Reisberg MA, Singer D, Suki WN, Duffy J, Hersh EM, Schloeder FX, Hill LL, Eknoyan G.
Medicine (Baltimore). 1979 Jan;58(1):65-79. doi: 10.1097/00005792-197901000-00004.
[C1q nephropathy. Report of one case].
Panuncio A, Alba A, Bacigalupe C, Caorsi H, Schwedt E, Otatti G, Saralegui P, Mariño A.
Rev Med Chil. 2008 Oct;136(10):1307-10. Epub 2009 Jan 15.
Measles and acute glomerulonephritis.
Lin CY, Hsu HC.
Pediatrics. 1983 Mar;71(3):398-401.
Dermatomyositis with membranous nephropathy.
Soylu A, Kavukçu S, Türkmen M, Saroğlu S.
Turk J Pediatr. 2001 Apr-Jun;43(2):143-5.
Clinical presentation and monitoring of lupus nephritis.
Balow JE.
Lupus. 2005;14(1):25-30. doi: 10.1191/0961203305lu2055oa.
Anti-DNA antibodies cross-react with C1q.
Franchin G, Son M, Kim SJ, Ben-Zvi I, Zhang J, Diamond B.
J Autoimmun. 2013 Aug;44:34-9. doi: 10.1016/j.jaut.2013.06.002. Epub 2013 Jul 5.
[C1Q NEPHROPATHY: CASE REPORTS AND LITERATURE REVIEW].
Galešić K, Horvatić I, Batinić D, Milošević D, Saraga M, Durdov MG, Ljubanović DG.
Lijec Vjesn. 2015 Sep-Oct;137(9-10):283-7.
[Clinical aspects of the complement system].
Tsukamoto H, Horiuchi T.
Rinsho Byori. 2006 Jul;54(7):757-62.
